The largest database of trusted experimental protocols

Heizbad hei vap

Manufactured by Heidolph
Sourced in Germany

The Heizbad Hei-VAP is a laboratory equipment product manufactured by Heidolph. It serves as a heating bath used for various applications in the laboratory setting.

Automatically generated - may contain errors

4 protocols using heizbad hei vap

1

Preparation of Polyphenol-Rich Extracts

Check if the same lab product or an alternative is used in the 5 most similar protocols
In order to obtain the samples for LC-MS analysis, liquid extracts (the samples obtained under the optimal extraction conditions in every employed extraction technique for achieving the highest polyphenol content) were dried. Additionally, the samples for FT-IR spectroscopy, antimicrobial, and skin regeneration potential analyses were lyophilized. The ethanol from the extracts was evaporated using Heizbad Hei-VAP (Heidolph, Schwabach, Germany) at 40–50 °C, a pressure of 50 mbar, and a rotation speed of 150 rpm. Subsequently, the sample was frozen in the freezer, at −80 °C for 1 h, and freeze-dried at −75 °C and pressure of 0.011 mbar for 24 h and at −65 °C and pressure of 0.054 mbar for one additional hour (Alpha 2-4 LSCplus, Christ, Osterode am Harz, Germany).
+ Open protocol
+ Expand
2

Anaphylactoid Potential Screening Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Five milliliters of each subfraction was concentrated and freeze-dried in a Heidolph Rotary Evaporator (Heizbad Hei-VAP, Heidolph Instruments GmbH & CO. KG, Germany) and Biocool Freeze Dryer (Biocool FD-1C-50, Boyikang, Beijing), respectively. The obtained powders were weighed and added to the RPMI 1640 culture media with 1% DMSO, and the final concentration of each solution was 200 μg/mL.
Exponentially growing RBL-2H3 cells in 6-well dishes were washed with PBS 3 times. Two milliliters of the tested supernatant was added to the corresponding wells, including the negative control group (RPMI 1640 culture media with 1% DMSO) and the positive control group (C 48/80; 20 μg/mL). Each group was made in triplicate. The 6-well dishes were incubated in an incubator (37°C, 5% CO2) for 30 min before the supernatants were discarded. The dishes were placed under an inverted microscope (Nikon Eclipse TS100-F, Japan) for observation. The groups with high degranulation rates were considered to have the potential constituents of the anaphylactoid reaction.
+ Open protocol
+ Expand
3

Evaporation, Gelatin Incorporation, and Freeze/Spray Drying of Liquid Extracts

Check if the same lab product or an alternative is used in the 5 most similar protocols
In order to evaporate ethanol from liquid extracts, the samples were placed in rotary evaporator Heizbad Hei-VAP (Heidolph, Berlin, Germany) at 40–50 °C, pressure of 50 mbar and rotation speed of 150 rpm. Subsequently, 50 mL of liquid extract without ethanol was mixed with 2.5 g of gelatin and the mixture was stirred on the magnetic stir plate, RTC basic (IKA, Königswinter, Germany), at 40 °C for approximately 15 min.
Before the lyophilization, the samples (dissolved gelatin, pure extracts and extracts with 5% w/w of gelatin) were frozen in freezer, LAB11/EL19LT (Elcold, Hobro, Denmark), at −80 °C for 1 h. In freeze dryer Beta 2–8 LD plus (Christ, Osterode am Harz, Germany), main drying was carried out at −75 °C and pressure of 0.011 mbar for 24 h and final drying at −65 °C and pressure of 0.054 mbar for 1 h.
Spray drying of dissolved gelatin, pure extracts and extracts with 5% w/w of gelatin was performed in Mini Spray Dryer B-290 (Büchi, Flawil, Switzerland) equipped with nozzle of 0.7 mm. The inlet temperature was 140 °C, while outlet temperature was 72–75 °C. The air flow rate was 45 mm and the rate of liquid feed was 30%.
+ Open protocol
+ Expand
4

Emulsion Solvent Evaporation for PLGA Nanoparticles

Check if the same lab product or an alternative is used in the 5 most similar protocols
An emulsion/solvent evaporation method was used to prepare NPs by nanoprecitation with slight modifications [20 (link)]. In which, different concentrations of PLGA (Table 1) and rosuvastatin and ezetimibe were accurately weighted and dissolved in 15 ml organic phase (chloroform). The organic phase was added under magnetic stirring to a previously prepared aqueous solution of pluronic F-127 acid polymer with different percentages (Table 1). Particle precipitation occurred immediately. After 10 min, the organic solvent was removed under vacuum at 30°C using a rotavapor (Heizbad Hei-VAP; Heidolph). Empty NPs were prepared according to the procedure previously described. When purified, the samples were recovered from suspension by vacuum ultrafiltration.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!